GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (OTCPK:ACHFF) » Definitions » Price-to-Free-Cash-Flow

ACHFF (Arch Biopartners) Price-to-Free-Cash-Flow : N/A (As of Apr. 14, 2025)


View and export this data going back to 2009. Start your Free Trial

What is Arch Biopartners Price-to-Free-Cash-Flow?

As of today (2025-04-14), Arch Biopartners's share price is $1.33. Arch Biopartners's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.02. Hence, Arch Biopartners's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Arch Biopartners's Price-to-Free-Cash-Flow or its related term are showing as below:

ACHFF's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 28.78
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Arch Biopartners's Free Cash Flow per Share for the three months ended in Dec. 2024 was $-0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-0.02.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 8.90% per year.

During the past 13 years, Arch Biopartners's highest 3-Year average Free Cash Flow per Share Growth Rate was 68.40% per year. The lowest was -61.60% per year. And the median was 8.90% per year.


Arch Biopartners Price-to-Free-Cash-Flow Historical Data

The historical data trend for Arch Biopartners's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arch Biopartners Price-to-Free-Cash-Flow Chart

Arch Biopartners Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 376.25 - -

Arch Biopartners Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Dec24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Arch Biopartners's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Arch Biopartners's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arch Biopartners's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Biopartners's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Arch Biopartners's Price-to-Free-Cash-Flow falls into.


;
;

Arch Biopartners Price-to-Free-Cash-Flow Calculation

Arch Biopartners's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=1.33/-0.016
=N/A

Arch Biopartners's Share Price of today is $1.33.
Arch Biopartners's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Arch Biopartners  (OTCPK:ACHFF) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Arch Biopartners Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Arch Biopartners's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Arch Biopartners Business Description

Traded in Other Exchanges
Address
545 King Street West, Toronto, ON, CAN, M5V 1M1
Arch Biopartners Inc is a late-stage clinical trial company focused on preventing acute kidney injury and organ damage caused by inflammation. The company is developing a platform of novel drugs that target the dipeptidase-1 (DPEP1) inflammation pathway, which is prevalent in the kidneys, lungs, and liver.

Arch Biopartners Headlines

From GuruFocus